Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FZL16
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $64,685
Award facts
- Contract value 100% obligated
- $64,685.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $64,685 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for 200-unit vials of Botox, with an ultimate completion date of October 7, 2025. The order will be performed in Park Ridge, Illinois, where the vendor is headquartered. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $499.999 billion and extending through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has been registered in the System for Award Management since 2001 and specializes in supplying branded and generic medications, biologics, and medical consumables to federal agencies. The contract award carries no set-aside designation, indicating the vendor competed directly in the open market. As a key supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has secured multiple delivery orders covering diverse medical products ranging from oncology treatments to specialty injections and vaccines, reinforcing its critical role in supporting military health operations.
Quick answers
Who was awarded contract SPE2DB25FZL16?
SPE2DB25FZL16 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FZL16 worth?
The government has obligated $64,685 on SPE2DB25FZL16.
Is contract SPE2DB25FZL16 an order under another contract?
Yes. SPE2DB25FZL16 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZL16 competed?
The extent of competition for SPE2DB25FZL16 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award